According to the Zhitong Finance APP, Jiangsu Sihuan Bioengineering (000518.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 0.156 billion yuan, a 13.31% year-on-year decrease. The net loss attributable to shareholders of the listed company was 14.6172 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 16.2974 million yuan.